GSK2879552 2HCl (1401966-69-5 (free base) )
GSK2879552 is an oral, irreversible inhibitor of Lysine-Specific Demethylase 1 (LSD1) developed for cancer research. It has demonstrated antineoplastic activity in studies targeting acute myeloid leukemia (AML) and small cell lung cancer (SCLC) in both in vitro and in vivo models.
Product Specifications
CAS Number
1902123-72-1
Product Name Alternative
LSD1, HistoneDemethylase, Histone Demethylase, GSK2879552 2HCl (1401966 69 5 (free base) ), GSK2879552 2HCl (1401966695 (free base) ), GSK-2879552 2HCl (1401966-69-5 (free base) ), GSK2879552 2HCl (1401966-69-5 (free base) )
Field of Research
Epigenetics & Chromatin
Purity
≥95% (May vary between batches)
Solubility
DMSO:4.38 mg/mL (10.01 mM)
Smiles
Cl.Cl.OC (=O) c1ccc (CN2CCC (CN[C@@H]3C[C@H]3c3ccccc3) CC2) cc1
Molecular Formula
C23H30Cl2N2O2
Molecular Weight
437.4
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740031-500 1x 500 µL
Mucin 5AC (MUC5AC) (45M1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942076-100 1x 100 µL
GFAP (Astrocyte & Neural Stem Cell Marker) (GFAP/2076), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742810-500 1x 500 µL
CELA3B / ELA3B (Pancreatic Function Marker) (CELA3B/2810R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details